Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $205,869 | 80 | 91.3% |
| Travel and Lodging | $14,886 | 64 | 6.6% |
| Food and Beverage | $3,879 | 77 | 1.7% |
| Consulting Fee | $800.00 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $208,557 | 192 | $0 (2024) |
| PFIZER INC. | $14,924 | 18 | $0 (2019) |
| Amgen Inc. | $1,156 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $500.00 | 2 | $0 (2018) |
| Tactile Systems Technology Inc | $132.85 | 2 | $0 (2017) |
| Medtronic, Inc. | $119.08 | 1 | $0 (2022) |
| BOSTON SCIENTIFIC CORPORATION | $23.68 | 1 | $0 (2017) |
| Silk Road Medical, Inc. | $20.91 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,089 | 16 | Janssen Pharmaceuticals, Inc ($18,031) |
| 2023 | $11,071 | 10 | Janssen Pharmaceuticals, Inc ($11,071) |
| 2022 | $30,349 | 35 | Janssen Pharmaceuticals, Inc ($30,195) |
| 2021 | $31,656 | 26 | Janssen Pharmaceuticals, Inc ($31,625) |
| 2020 | $10,088 | 9 | Janssen Pharmaceuticals, Inc ($10,055) |
| 2019 | $82,419 | 76 | Janssen Pharmaceuticals, Inc ($77,748) |
| 2018 | $14,328 | 13 | Janssen Pharmaceuticals, Inc ($12,328) |
| 2017 | $26,436 | 39 | Janssen Pharmaceuticals, Inc ($17,505) |
All Payment Transactions
224 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,255.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,255.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/09/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $141.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/08/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,041.25 | General |
| Category: Cardiology | ||||||
| 04/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,255.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $140.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $93.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $5.73 | General |
| Category: Cardiology | ||||||
| 03/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,720.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | In-kind items and services | $134.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $111.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,720.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/07/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $198.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/22/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,525.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/22/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,055.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $123.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $112.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/15/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $91.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/17/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $104.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/04/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/23/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,525.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/23/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $137.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 330 | 453 | $240,963 | $37,757 |
| 2022 | 9 | 350 | 458 | $222,343 | $39,597 |
| 2021 | 9 | 336 | 471 | $190,241 | $43,026 |
| 2020 | 8 | 345 | 508 | $179,272 | $39,262 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 119 | 180 | $83,310 | $12,031 | 14.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 66 | 95 | $61,921 | $9,648 | 15.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 51 | 51 | $40,289 | $6,949 | 17.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 58 | 90 | $41,670 | $6,145 | 14.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 17 | 17 | $7,234 | $2,171 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 20 | $6,539 | $813.28 | 12.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 116 | 176 | $76,460 | $12,689 | 16.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 53 | 72 | $42,772 | $7,817 | 18.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 51 | 51 | $37,935 | $6,539 | 17.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 34 | $11,870 | $2,568 | 21.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 16 | 16 | $6,512 | $2,052 | 31.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 21 | 28 | $11,433 | $2,034 | 17.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $12,166 | $2,006 | 16.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 35 | 39 | $11,720 | $1,662 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 13 | $5,257 | $1,186 | 22.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 11 | 11 | $6,218 | $1,043 | 16.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 50 | 116 | $40,400 | $9,418 | 23.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 77 | 118 | $43,312 | $8,432 | 19.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 38 | 39 | $26,349 | $5,844 | 22.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 23 | 39 | $19,191 | $4,445 | 23.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 28 | 28 | $10,278 | $3,586 | 34.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 33 | $12,165 | $3,280 | 27.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 19 | 19 | $13,278 | $2,769 | 20.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 23 | 23 | $12,694 | $2,360 | 18.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 39 | 43 | $10,896 | $2,021 | 18.5% |
About Dr. Christopher Foley, MD
Dr. Christopher Foley, MD is a Cardiovascular Disease healthcare provider based in Edina, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609831205.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Foley, MD has received a total of $225,434 in payments from pharmaceutical and medical device companies, with $19,089 received in 2024. These payments were reported across 224 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($205,869).
As a Medicare-enrolled provider, Foley has provided services to 1,361 Medicare beneficiaries, totaling 1,890 services with total Medicare billing of $159,643. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Edina, MN
- Active Since 04/18/2006
- Last Updated 04/11/2017
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1609831205
Products in Payments
- XARELTO (Drug) $208,557
- ELIQUIS (Drug) $15,424
- Repatha (Biological) $1,156
- FLEXITOUCH (Device) $132.85
- RESOLUTE ONYX (Device) $119.08
- STERLING BALLOON DILATATION CATHETERS (Device) $23.68
- ENROUTE Transcarotid Neuroprotection System (Device) $20.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Edina
Eric Ernst, M.d, M.D
Cardiovascular Disease — Payments: $148,501
Timinder Biring, Md, MD
Cardiovascular Disease — Payments: $38,477
Dr. Dominic Plucinski, Md, MD
Cardiovascular Disease — Payments: $36,039
Steven Heifetz, M.d, M.D
Cardiovascular Disease — Payments: $18,854
Demosthenes Iskos, Md, MD
Cardiovascular Disease — Payments: $10,249
Joseph Knapper, M.d, M.D
Cardiovascular Disease — Payments: $4,045